Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan · Delayed Price · Currency is TWD

36.30

+0.85 (2.40%)

May 29, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Developing New Biotech Drugs and Selling Biotech Products	67.27M	167.57M	314.50M	-	-
Developing New Biotech Drugs and Selling Biotech Products Growth	-59.86%	-46.72%	-	-	-
Total	67.27M	167.57M	314.50M	-	-
Total Growth	-59.86%	-46.72%	-	-	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Taiwan	-	75.00K	314.50M	-	-
Taiwan Growth	-	-99.98%	-	-	-
United States	67.27M	167.49M	-	-	-
United States Growth	-59.84%	-	-	-	-
Total	67.27M	167.57M	314.50M	-	-
Total Growth	-59.86%	-46.72%	-	-	-

Source: S&P Global Market Intelligence.